Article
Italian Tribunal Overturns Competition Authority’s Decision In Pfizer Patent Misuse Case
On 3 September 2012, the Italian Administrative Tribunal for Lazio ("Tribunale Amministrativo di Lazio", the "Tribunal") annulled an earlier decision of the Italian Competition Authority ("Autorità Garante della Concorrenza e del Mercato", the "Authority") which had fined pharmaceutical group Pfizer € 10.6 million for abuse of dominance in the market for medicines based on the active substance latanoprost for the treatment of glaucoma (see VBB on Competition Law, Volume 2012, No. 1, available at
Van Bael & Bellis